Advanced Prostate Cancer Consensus Conference (APCCC 2021)
Viewing 21-28 of 28 articles
APCCC 2021: Do We Need the Second PET (FDG) for Patient Selection? (Including SUV for Selection of PSMA Therapy)
APCCC 2021: What Is the Evidence for “Triplet Therapy” (ADT + Radiation of the Primary + Additional Systemic Therapy)?
APCCC 2021: “Triplet Therapy” for Metastatic Hormone-Sensitive Prostate Cancer, (ADT + Radiation of the Primary + Additional Systemic Therapy)